Treatment of leukoaraiosis

Current Treatment Options in Cardiovascular Medicine

Volumn 7, Issue 3, 2005, Pages 173-177

  Schwartz, Gary L ^a   Fornage, Myriam ^b   Mosley, Thomas ^b   Turner, Stephen T ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; PYRIDOXINE;

AGING; BLOOD PRESSURE REGULATION; CAROTID ARTERY DISEASE; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; DRINKING BEHAVIOR; HOMOCYSTINURIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEUKOARAIOSIS; LIFESTYLE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; SMOKING HABIT; STROKE; WEIGHT REDUCTION; WHITE MATTER;

EID: 27744599368     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-005-0045-8     Document Type: Review

References (35)

1. de Leeuw FE, de Groot JC, Achten E, et al.: Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001, 70:9-14.
2. Hachinski VC, Potter P, Merskey H: Leuko-araiosis: an ancient term for a new problem. Can J Neurol Sci 1986, 13:533-534.
3. Wong TY, Klein R, Sharrett AR, et al.: Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002, 288:67-74.
4. Kuller LH, Longstreth WT Jr, Arnold AM, et al.: White matter hyperintensity on cranial magnetic resonance imaging. A predictor of stroke. Stroke 2004, 35:1821-1825.
5. de Groot JC, de Leeuw FE, Oudkerk M, et al.: Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000, 47:145-151.
6. Dufouil C, Alperovitch A, Tzourio C: Influence of education on the relationship between white matter lesions and cognition. Neurology 2003, 60:831-836.
7. Longstreth WT Jr, Manolio TA, Arnold A, et al.: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996, 27:1274-1282.
8. Prins ND, van Dijk EJ, den Heijer T, et al.: Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004, 61:1531-1534.
9. Brun A, Englund E: White matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986, 19:253-262.
10. Liao D, Cooper L, Cai J, et al.: The prevalence and severity of white matter lesions, their relationship with age, gender, and cardiovascular risk factors: the ARIC Study. Neuroepidemiology 1997, 16:149-162.
11. Jeerakathil T, Wolf PA, Beiser A, et al.: Stroke risk profile predicts white matter hyperintensity volume. The Framingham Study. Stroke 2004, 35:1857-1861.
12. DeCarli C, Miller BL, Swan GE, et al.: Predictors of brain morphology for the men of the NHLBI Twin Study. Stroke 1999, 30:529-536.
13. Ylikoski A, Erkinjuntti T, Raininko R, et al.: White matter hyperintensities on MRI in the neurologically non-diseased elderly: analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995, 26:1171-1177.
14. van Dijk EJ, Vermeer SE, de Groot JC, et al.: Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry 2004, 75:733-736.
15. den Heijer T, Vermeer SE, van Dijk EJ, et al.: Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia. Am J Clin Nutr 2004, 80:992-997.
16. Swan GE, DeCarli C, Miller BL, et al.: Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 1998, 51:986-993.
17. Liao D, Cooper L, Cai J, et al.: Presence and severity of cerebral white matter lesions and hypertension, it treatment, and control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996, 27:2262-2270.
18. de Leeuw FE, de Groot JC, Oudkerk M, et al.: A follow-up of blood pressure and cerebral white matter lesions. Ann Neurol 1999, 46:827-833.
19. van Dijk EJ, Breteler MM, Schmidt R, et al.: The association between blood pressure, hypertension, and cerebral white matter lesions. Cardiovascular Determinants of Dementia Study. Hypertension 2004, 44:625-630.
20. Carmelli D, Swan GE, Reed T, et al.: Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology 1999, 52:1119-1124.
21. Sachdev P, Parslow R, Salonikas C, et al.: Homocysteine and the brain in midadult life. Evidence for an increased risk of leukoaraiosis in men. Arch Neurol 2004, 61:1369-1376.
22. Hassan A, Hunt BJ, O'Sullivan M, et al.: Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004, 127:212-219.
23. Cadelo M, Inzitari D, Pracucci G, et al.: Predictors of leukoaraiosis in elderly neurological patients. Cerebrovasc Dis 1991, 1:345-351.
24. Inzitari D, Giordano GP, Ancona AL, et al.: Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke 1990, 21:1419-1423.
25. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [no authors listed]. Arch Intern Med 1997, 157:2413-2446.
26. United States Renal Data System: Excerpts from the 2000 U.S. Renal Data System Annual Data Report: Atlas of End Stage Renal Disease in the United States. Am J Kidney Dis 2000, 36:S1-S279.
27. Hendrie HC: Epidemiology of dementia and Alzheimer's disease. Am J Geriatr Psychiatry 1998, 6(2 suppl 1):S3-S18.
28. Ho KK, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993, 22(4 suppl A):6A-13A.
29. The seventh report of the Joint National committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [no authors listed]. Hypertension 2003, 42:1206-1252.
30. American Diabetes Association: Standards of medical care in diabetes (position statement). Diabetes Care 2004, 27(suppl 1):S15-S35.
31. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) [no authors listed]. JAMA 2001, 285:2486-2497.
32. Grundy SM, Cleeman JI, Merz CN, et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227-239.
33. Streifler JY, Eliasziw M, Benavente OR, et al.: Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis. Stroke 2002, 33:1651-1655.
34. Streifler JY, Eliasziw M, Benavente OR, et al.: Development and progression of leukoaraiosis in patients with brain ischemia. and carotid artery disease. Stroke 2003, 34:1913-1917.
35. Turner ST, Jack CR, Fornage M, et al.: Heritability of leukoaraiosis in hypertensive sibships. Hypertension 2004, 43:483-487.